Association Between Treatment With Biologics and Cardiovascular Comorbidities in Patients With Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Interleukin-23 inhibition associates with lower incidence of cardiovascular risk factor type diseases compared to biologic naïve patients with psoriasis: A retrospective cohort study
J Am Acad Dermatol 2024 Oct 16;[EPub Ahead of Print], AO Vera, C Ro, W Adawi, A Yap, AS Van Voorhees, CW EnosFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.